Journal of Oncology Pharmacy Practice

Article	Citations
Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings	62
Fibroblast growth factor receptor (FGFR) inhibitors: A review of a novel therapeutic class	40
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors	29
A drug repositioning success: The repositioned therapeutic applications and mechanisms of action of thalidomide	27
Cancer patient experience of telephone clinics implemented in light of COVID-19	25
Factors affecting health-related quality of life among prostate cancer patients: A systematic review	19
Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: A randomized, triple blind, placebo-controlled clinical trial	19
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab	19
ISOPP Standards for the Safe Handling of Cytotoxics	16
Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations	16
Cisplatin-induced nephrotoxicity in children: what is the best protective strategy?	16
Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review	16
Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving pembrolizumab	15
Cryotherapy for the prevention of chemotherapy-induced peripheral neuropathy: A systematic review	15
Spine eburnation in a metastatic lung cancer patient treated with immunotherapy and radiotherapy. The first case report of bystander effect on bone	15
Tofacitinib for treatment in immune-mediated myocarditis: The first reported cases	15
Metastatic penile squamous cell carcinoma with dramatic response to combined checkpoint blockade with ipilimumab and nivolumab	13
Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations	12
Bullous pemphigoid in elderly woman affected by non-small cell lung cancer treated with pembrolizumab: A case report and review of literature	12
Comparing the clinical efficacy and safety of abiraterone and enzalutamide in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis	12
Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study	12
Applications and challenges in therapeutic drug monitoring of cancer treatment: A review	12
A real-world data approach to determine the optimal dosing strategy for pembrolizumab	12
Adverse reactions and adherence to capecitabine: A prospective study in patients with gastrointestinal cancer	11
Incidence of hemorrhagic cystitis after cyclophosphamide therapy with or without mesna: A cohort study and comprehensive literature review	11

Prevalence of potential drug-drug interactions in breast cancer patients and determination of their risk factors	11
International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care	11
New onset diabetes with ketoacidosis following nivolumab immunotherapy: A case report and review of literature	11
Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab	11
The introduction of a third CDK4/6 inhibitor does not change the cost-effectiveness profile in first and subsequent-lines after progression or relapse during previous endocrine therapy in patients wit	11
Impact of pharmacist-managed immune checkpoint inhibitor toxicities	11
Safety of ninety-minute daratumumab infusion	10
Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program	10
Impact of clinical pharmacy in oncology and hematology centers: A systematic review	10
Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety	10
Dermatological side effects of immunotherapy drugs and targeted cancer therapies: Importance of dermatology and oncology collaboration	10
Management of skin adverse reactions in oncology	10
Assessment of hospitalization rates for immune-related adverse events with immune checkpoint inhibitors	10
Severe rhabdomyolysis induced by possible drug–drug interaction between Ribociclib and Simvastatin	9
Interpersonal communication-, education- and counselling-based interventions to support adherence to oral anticancer therapy: a systematic review	9
Use of active learning and simulation to teach pharmacy students order verification and patient education best practices with oral oncolytic therapies	9
Thyroid cancer risk factors and Pakistani University students’ awareness towards its preventive practice	9
Larotrectinib followed by selitrectinib in a novelDCTN1–NTRK1fusion undifferentiated pleomorphic sarcoma	9
A deep dive into CDK4/6 inhibitors: Evaluating real world toxicities and treatment paradigms in the elderly population	9
The safe handling of chemotherapy drugs in low- and middle-income countries: An overview of practices	9
Successful rechallenge of alectinib after remission of severe alectinib-induced interstitial lung disease	9
Immune-related myocarditis in two patients receiving camrelizumab therapy and document analysis	8
ISOPP 2023 – Abstract Book	8
Ambulatory chemotherapy: Past, present, and future	8
Lorlatinib induced proteinuria: A case report	8
A real world analysis of first line treatment of advanced EGFR mutated non-small cell lung cancer: A multi-center, retrospective study	8
Newly approved anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory diffuse large B-cell lymphoma	8
Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation	8
Sensitivity and specificity of drug interaction databases to detect interactions with recently approved oral antineoplastics	8
A new treatment of alopecia induced by palbociclib: Topical cetirizine	8
Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital	8
Anticancer agents and phytotherapy: Interactions that are often unrecognized	8
Routine antiemetic prophylaxis with dexamethasone during COVID-19: Should oncologists reconsider?	8
A review of Osimertinib in NSCLC and pharmacist role in NSCLC patient care	8
Temozolomide-induced aplastic anaemia: Case report and review of the literature	8
A possible mechanism of hyperlipidemia in a patient with metastatic non-small cell lung cancer on lorlatinib therapy	8
Ribociclib induced acute kidney injury: A case report	8
Medication discrepancies in hospitalized cancer patients: Do we need medication reconciliation?	8
Occupational exposure assessment in professionals who manipulate and administer antineoplastic drugs in a university hospital in Southern Brazil	8
Global changes to the chemotherapy service during the covid-19 pandemic	8
Characterization of relapse patterns in patients with acute lymphoblastic leukemia treated with blinatumomab	7
Non-pharmacological integrative therapies for chronic cancer pain	7
Pembrolizumab-induced severe rejection and graft intolerance syndrome resulting in renal allograft nephrectomy	7
Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study	7
Classical Hodgkin lymphoma-like post-transplant lymphoproliferative disease after allogeneic stem cell transplantation for primary myelofibrosis is successfully treated with nivolumab: A case report	7
Methylene blue and ifosfamide-induced encephalopathy: Myth or reality?	7
Case report on 5-fluorouracil induced cerebrovascular accident	7
Revisiting same day administration of pegfilgrastim in the age of biosimilars: A review of literature	7
Closed-system transfer device use with oncology biologics: A survey of Canadian healthcare practitioners	7
Knowledge, attitude, preventive practices and perceived barriers to screening about colorectal cancer among university students of newly merged district, Kpk, Pakistan – A cross-sectional study	7

Outcomes with enoxaparin dose reductions during thrombocytopenia in patients with hematopoietic stem cell transplantation (HSCT)	7
Impact of clinical pharmacists in an inpatient medical oncology service: A prospective study at a comprehensive cancer center in Jordan	7
The emergence of b-cell maturation antigen (BCMA) targeting immunotherapy in multiple myeloma	7
Bromocriptine for the treatment of postoperative cerebellar mutism syndrome in pediatric patients: Three case reports	7
Late-onset double-seronegative myasthenia gravis syndrome and myasthenic crisis due to nivolumab use for Hodgkin’s lymphoma	7
Nivolumab treatment for metastatic thymic epithelial tumors	7
Blood contamination of the pharmaceutical staff by irinotecan and its two major metabolites inside and outside a compounding unit	7
Assessment of Canadian patient education material for oncology pharmaceutics	7
Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology–oncology and transplant clinic: Assessment and significance	6
Involvement of C677T MTHFR variant but not A1298C in methotrexate-induced toxicity in acute lymphoblastic leukemia	6
Use of immunotherapy with programmed cell death 1 vs programmed cell death ligand 1 in renal cell carcinoma: Lessons from CheckMate 9ER and IMmotion 151	6
Recent progress in immunotherapy of breast cancer targeting the human epidermal growth factor receptor 2 (HER2)	6
New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma	6
Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report	6
Two different immune related adverse events occured at pancreas after nivolumab in an advanced RCC patient	6
Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer	6
Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma	6
Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City	6
Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum	6
Significant interaction between high-dose methotrexate and high-dose piperacillin-tazobactam causing reversible neurotoxicity and renal failure in an osteosarcoma patient	6
Clinical pharmacy in onco-hematology and bone marrow transplant: A valuable contribution to improving patient safety	6
Perception, knowledge, and handling practice regarding the risk of exposure to antineoplastic drugs in oncology day hospitalization units and compounding unit staff	6
Hypersensitivity reactions to paclitaxel: The Mexican experience of rapid desensitization	6
Unleashing the power of immunotherapy and targeted therapy combinations: Advancing cancer care or discovering unknown toxicities?	6
Advanced papillary thyroid carcinoma responding to nivolumab	6
Dosing errors in total parenteral nutrition prescriptions at a specialized cancer care hospital of Lahore: The role of clinical pharmacist	6
A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer	6
Ifosfamide induced encephalopathy in a child with osteosarcoma	6
A rare case of gastric cancer with bilateral breast metastasis during pregnancy	6
Acute cytokine release syndrome after a first dose of pembrolizumab as second-line treatment for metastatic, programmed death-ligand 1-positive, non-small-cell lung cancer	6
Bluish-gray fingernail discoloration due to the use of nivolumab	6
Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma	6
Barriers and facilitators for the safe handling of antineoplastic drugs	6
Role of clinical pharmacist in the palliative care of adults and elderly patients with cancer: A scoping review	6
A clinical approach to non-neutropenic fever in children with cancer	6
Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma	6
Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease	6
Evaluation of a patient self-medication program in allogeneic hematopoietic stem cell transplantation	6
Pharmacological interventions for preventing anthracycline-induced clinical and subclinical cardiotoxicity: A network meta-analysis of metastatic breast cancer	6
Increasing pharmacy productivity and reducing medication turnaround times in an Italian comprehensive cancer center by implementing robotic chemotherapy drugs compounding	6
Progress in oncology biosimilars till 2020: Scrutinizing comparative studies of biosimilar monoclonal antibodies	6
Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold	6
Initial tacrolimus weight-based dosing strategy in allogeneic hematopoietic stem-cell transplantation	5
Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature	5
Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report	5
Nelarabine-associated myelopathy in a patient with acute lymphoblastic leukaemia: Case report	5
Delayed immune thrombocytopenia after discontinuation of nivolumab therapy: A case report and literature review	5
Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions	5
Hypertriglyceridemia induced by S-1: A novel case report and review of the literature	5
Impact of anti-cancer drugs shortages in oncology and hematology departments in a Moroccan hospital	5
A second administration of glucarpidase in a different cycle of high-dose methotrexate: Is it safe and effective in adults?	5
A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis	5
Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study	5
Patterns of complementary and alternative medicine use among Tunisian cancer patients	5
Panuveitis in patient on ipilimumab/nivolumab combination for small-cell lung cancer treated with an intravitreal dexamethasone implant	5
Successful alectinib desensitization in a patient with anaplastic lymphoma kinase-positive adenocarcinoma of the lung and alectinib-induced drug rash	5
A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma	5
Pazopanib-related secondary polycythemia in metastatic myxofibrosarcoma: A case report and review of the literature	5
Feasibility of preemptive pharmacogenetic testing in colorectal cancer patients within a community oncology setting	5
Immediate severe hypersensitivity reaction to etoposide phosphate: Case report and review of the literature	5
Retrospective analysis of the incidence and severity of acute kidney injury (AKI) in patients with head and neck cancer receiving weekly cisplatin with radiotherapy (RAISe-AKI)	5
Evaluation of external contamination on the vial surfaces of some hazardous drugs that commonly used in Chinese hospitals and comparison between environmental contamination generated during robotic co	5
The efficacy and safety of alpelisib in breast cancer: A real-world analysis	5
Blinatumomab use in pediatric ALL: Taking a BiTE out of preparation, administration and toxicity challenges	5
Awareness is the first step: What Ghanaian community pharmacists know about cancer	5
Predictors of tyrosine kinase inhibitor adherence trajectories in patients with newly diagnosed chronic myeloid leukemia	5
The drugs screened by OncoVeeTM-Mini-PDX have significantly benefited the patient with HER2-positive advanced gastric cancer	5
Impact of obesity on safety outcomes and treatment modifications with ado-trastuzumab emtansine in breast cancer patients	5
Glioblastoma and bevacizumab in elderly patients: Monocentric study	5
Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy program	5
Case of metastatic kaposi sarcoma successfully treated with anti-PD-1 immunotherapy	5
Breastfeeding in a patient with chronic myeloid leukemia during tyrosine kinase inhibitor therapy	5
Sustained erythrocytosis due to the use of Lenvatinib	5
Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?	5
Impact of metformin on tyrosine kinase inhibitor response in chronic myeloid leukemia	5
Central diabetes insipidus induced by temozolomide: A report of two cases	5
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia	5
Rhabdomyolysis and acute kidney injury induced by the association of rosuvastatin and abiraterone: A case report and review of the literature	5
Dosing of PD-1 and PD-L1 inhibitors: Cost saving initiatives for significantly decreasing associated expenditure	5
Trousseau’s syndrome in a non-small cell lung cancer patient aggravated by pembrolizumab	5

Fatal hepatitis B reactivation in a patient receiving chemoradiation for cervical cancer	5
Adherence to thalidomide in patients with multiple myeloma: A cross-sectional study in a Brazilian metropolis	5
Capecitabine induced Steven–Johnson syndrome: A rare case report	5
Osimertinib induced cardiac failure and QT-prolongation in a patient with advanced pulmonary adenocarcinoma	5
Abstracts	5
Differences in safety profiles of newly approved medications for multiple myeloma in real-world settings versus randomized controlled trials	5
Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodies	5
Cyto-SAT: A self-assessment tool for the safe handling of cytotoxic drugs adapted for use in low- and middle-income countries	5
Real-world evidence of poly ADP-ribose polymerase inhibitors in the treatment of ovarian cancer: A systematic literature review	4
Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists	4
Tyrosine kinase inhibitors and COVID-19	4
Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation	4
Risk reduction in a cancer chemotherapy production unit: Contribution of an automated drug dispensing system	4
Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia	4
Influence of the implementation of a multidisciplinary consultation program on adherence to the first ever course of oral antineoplastic treatment in patients with cancer	4
Monoclonal antibody extravasations: Two case reports and literature review	4
Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancer	4
Brentuximab vedotin in real life, a seven year experience in patients with refractory/relapsed CD30+ T cell lymphoma	4
Development of carpal tunnel syndrome in association with checkpoint inhibitors	4
Osteonecrosis of the jaw under palbociclib: A case series description	4
Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia	4
Atypical response patterns in metastatic melanoma and renal cell carcinoma patients treated with nivolumab: A single center experience	4
A review on radiation induced nausea and vomiting: “Current management strategies and prominence of radio sensitizers”	4
Unmet supportive care needs and predictor of breast cancer patients in Bangladesh: A cross-sectional study	4
Real-world data on patients with metastatic non-small-cell lung cancer treated with checkpoint inhibitors in an Italian Teaching Hospital in 2015–2018	4
Anti-drug antibodies anti-trastuzumab in the treatment of breast cancer	4
Suggestion of Tunisia’s medical oncologist in the management of breast cancer during COVID-19 pandemic	4
Unmet supportive care needs and determinants among cancer patients treated at University of Gondar Specialized Hospital, Northwest Ethiopia: A prospective cross-sectional study	4
Contribution of an anticancer drug compounding robot in reducing the risks of manual preparation in a hospital pharmacy unit specialized in oncology	4
The role and economics of immunotherapy in solid tumour management	4
Vascular endothelial growth factor inhibitor induced hypertension: Retrospective analysis of the impact of blood pressure elevations on outcomes	4
Newly approved and forthcoming T-cell-redirecting bispecific antibodies for the treatment of relapsed/refractory multiple myeloma	4
Gilteritinib administration in a hemodialysis patient	4
Topical aloe vera for the treatment of cetuximab-related acneiform rash in colorectal cancer: A case report	4
MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: A meta-analysis	4
Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case	4
Fluconazole-Induced adrenal insufficiency following allogeneic hematopoietic cell transplant	4
Incidence of ifosfamide induced encephalopathy in patients receiving concomitant fosaprepitant	4
Novel agents for myelodysplastic syndromes	4
Identification of target small molecule tyrosine kinase inhibitors that need monitoring and clinical application of protocol for early detection of cancer therapeutics-related cardiac dysfunction usin	4
Pericardial effusion with pembrolizumab	4
Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report	4
A pharmacist’s review of the treatment of systemic light chain amyloidosis	4
HER-2 Neu gene: A valuable therapeutic target in metastatic mucoepidermoid carcinoma	4
Pemetrexed-induced Sweet Syndrome: First case report in the medical literature	4
Preservation of cognitive function after brain irradiation	4
Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendations	4
Anaphylaxis related to disinfection with chlorhexidine in a teenager treated for cancer	4
Risk assessment of personnel exposure in a central cytotoxic preparation unit using the FMECA method	4
Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion	4
Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards	4
Clinical pharmacy services in an ambulatory oncology clinic: Patient perception and satisfaction	4
Addressing the Challenges of Novel Oncology and Hematology Treatments Across Sites of Care: Specialty Pharmacy Solutions	4
Impact of low- and high-risk operators handling irinotecan on the blood contamination of health care workers in oncology day care units	4
Evaluation and clinical impact of a pharmacist-led, interdisciplinary service focusing on education, monitoring and toxicity management of immune checkpoint inhibitors	4
Educational needs of oncology pharmacists: A survey by the International Society of Oncology Pharmacy Practitioners	4
The role of fentanyl in the treatment of breakthrough cancer pain: Different biotechnologies, different results and different drug costs	4
Updates on the molecular mechanisms of aspirin in the prevention of colorectal cancer: Review	4
Rucaparib and olaparib for the treatment of prostate cancer: A clinician's guide to choice of therapy	4
Case report of sacituzumab govitecan-hziy-induced neutropenia in a patient with metastatic triple-negative breast cancer and a uridine diphosphate glucuronosyltransferase family 1 member A1 poor metab	4
Extemporaneous compounding and administration of tretinoin slurry for acute promyelocytic leukemia	4
Capecitabine-induced leukoencephalopathy in a patient with triple-negative breast cancer: A case report and review of the literature	4
Ifosfamide-related encephalopathy with severe clinical presentations in children with cancer	4
Thrombotic Thrombocytopenic Purpura associated with Pembrolizumab	4
Veliparib for the treatment of solid malignancies	4
The cost-effectiveness of new first-line therapies approved in advanced hepatocellular carcinoma	3
Organization of chemotherapeutic preparations in advance: Do we save or waste money?	3
Evaluation of voriconazole related adverse events in pediatric patients with hematological malignancies	3
Accurate determination of glomerular filtration rate in adults for carboplatin dosing: Moving beyond Cockcroft and Gault	3
Oncology boot camp: A preparatory curriculum for advanced pharmacy practice experience students	3
A study to assess the impact of pharmaceutical care services to cancer patients in a tertiary care hospital	3
Co-existence of BCR-ABL and JAK2V617F mutation in resistant chronic myeloid leukemia in the imatinib era: Is there a correlation?	3
The role of ado-trastuzumab emtansine in current clinical practice	3
Dinutuximab in adult-onset chemotherapy refractory high-risk neuroblastoma	3
Venetoclax ramp-up with concurrent voriconazole in a patient with chronic lymphocytic leukemia	3
Pharmacist value-added to neuro-oncology subspecialty clinics: A pilot study uncovers opportunities for best practices and optimal time utilization	3
Recurrent arthritis as an unexpected side effect associated with azacitidine in a patient with myelodysplastic syndrome	3
Optimizing the role of ambulatory chemotherapy in response to the Covid-19 pandemic	3
Age demographics of subjects enrolled in interventional phase 3 multiple myeloma clinical trials	3
Clinical and Economic Impact of Pharmacists’ Intervention on Care of Pediatric Hematology and Oncology Patients	3
Life-threatening sustained hypocalcemia following Denosumab use in metastatic prostate cancer	3
Consensus Recommendations for the Safe Handling of Cytotoxic Agents in Cytotoxic Academic Research Laboratories (CARL)	3
Cost analysis of daratumumab therapy: Is there a cost benefit to using the recently approved subcutaneous product versus the IV product?	3
Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with aDPYDvariant and decreased dihydropyrimidine dehydrogenase enzyme activity	3
Pharmacokinetic characterization, benefits and barriers of subcutaneous administration of monoclonal antibodies in oncology	3
Orbital myeloid sarcoma treated with low-dose venetoclax and a potent cytochrome P450 inhibitor	3
Analysis of immune-mediated reactions in patients with non-small cell lung cancer treated with nivolumab and its association with effectiveness	3
Impact of the implementation of a pharmacist-driven immunosuppression drug monitoring protocol for hematopoietic stem cell transplant recipients	3
Design and stability of pediatric oral formulation of imatinib	3
Acceptance of coronavirus disease 2019 vaccination by cancer patients in Cyprus: A cross-sectional study	3
Introduction of biosimilar pegfilgrastim in France: Economic analysis of switching from originator	3
Perspectives toward biosimilars among oncologists: A Malaysian survey	3
Nivolumab-induced pneumonitis and cardiopathy in a patient with relapsed Hodgkin's lymphoma	3
Rituximab desensitization in pediatric acute lymphoblastic leukemia with severe anaphylaxis	3
Interstitial nephritis with pembrolizumab: A case report and review	3